98%
921
2 minutes
20
This study explores the involvement of the subthalamic nucleus (STN) in executive functions, particularly cognitive flexibility, in Parkinson's disease (PD) patients. Utilizing a computerized Wisconsin Card Sorting Task (WCST) and local field potential (LFP) recordings from implanted deep brain stimulation (DBS) electrodes, we investigated task-specific neural dynamics. Behavioural results demonstrated increased error rates and prolonged response times in trials requiring set-shifting and rule induction via cross-temporal information integration. Electrophysiological analyses revealed integration-specific LFP modulations, including enhanced theta-band activity linked to conflict monitoring and cognitive control during high-demand trials, and beta-band suppression associated with motor inhibition and task disengagement. These findings underscore the STN's integrative role in non-motor domains, supporting its function in cross-temporal information integration for cognitive control. The results also highlight the utility of the WCST for assessing multiple executive processes and the potential of LFP-based biomarkers to refine DBS programming. Despite the relatively small sample size, this study provides novel insights into the oscillatory dynamics of the STN, emphasizing its broader role in decision-making and executive control. Future research should expand the understanding of the STN's contributions across cognitive domains.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neuroscience.2025.04.006 | DOI Listing |
Eur J Neurol
September 2025
Department of Neuroscience 'Rita Levi Montalcini', University of Torino, Torino, Italy.
Background: The factors contributing to a poor response to subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease (PD) are not yet fully understood. Accordingly, predicting the outcome might be challenging particularly in those who display an optimal response to the Levodopa challenge test.
Objective: To determine which factors may contribute to poor outcome of STN-DBS in PD.
Cureus
August 2025
Neurology, Emory University, Atlanta, USA.
Deep brain stimulation (DBS) and the use of directional subsegmental stimulation have significantly advanced symptom management in patients with Parkinson's disease (PD) and essential tremor (ET). This study examines the use of directional programming in a tertiary care center. We retrospectively reviewed medical records of 12 PD patients (all with bilateral subthalamic nucleus (STN) implants) and 13 ET patients (12 with bilateral and 1 with unilateral ventral intermediate nucleus (VIM) implants) who received directional leads.
View Article and Find Full Text PDFCureus
August 2025
Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, USA.
Freezing of gait (FoG) is a disabling symptom of Parkinson's disease (PD) characterized by involuntary cessation/reduction. While deep brain stimulation (DBS) targeting the subthalamic nucleus (STN) effectively treats common PD symptoms such as tremor, its impact on FoG is less clear. Rarely, STN-DBS itself can induce FoG.
View Article and Find Full Text PDFBrain Stimul
September 2025
Department of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing, China; Department of Neurosurgery, Neuromedicine Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Electronic address:
Background: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has emerged as an effective therapy for Meige syndrome (MS). However, the optimal stimulation site within STN and the most effective stimulation fiber tracts have not been investigated.
Methods: Based on the discovery cohort (n = 65), we first identified the optimal stimulation site within the STN using the sweet spot mapping method.
Sleep Med Clin
September 2025
Parkinson Foundation Centre of Excellence, King's College Hospital and King's College, London, United Kingdom; King's College Hospital, London, Dubai, UAE; Institute of Psychiatry, Psychology and Neuroscience, King's College, Dementech Clinical Neuroscience Centre London, United Kingdom. Electronic
Sleep dysfunction is dominant in patients on oral dopamine replacement therapies as nighttime therapy is suboptimal and often not attempted. Non oral infusion-based Parkinson's disease (PD) therapies, transdermal therapies, as well as deep brain stimulation (DBS) of the subthalamic nucleus (STN) bridge this gap and provide nighttime cover in most cases in PD. DBS of the STN also show significant improvement in PD sleep scale scores and improvement in sleep quality.
View Article and Find Full Text PDF